Standardizing abortion research outcomes (STAR): Results from an international consensus development study.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
11 2021
Historique:
received: 21 04 2021
revised: 01 07 2021
accepted: 02 07 2021
pubmed: 18 7 2021
medline: 28 10 2021
entrez: 17 7 2021
Statut: ppublish

Résumé

To develop a minimum data set, known as a core outcome set, for future abortion randomized controlled trials. We extracted outcomes from quantitative and qualitative systematic reviews of abortion studies to assess using a modified Delphi method. Via email, we invited researchers, clinicians, patients, and healthcare organization representatives with expertise in abortion to rate the importance of the outcomes on a 9-point Likert scale. After 2 rounds, we used descriptive analyses to determine which outcomes met the predefined consensus criteria. We finalized the core outcome set during a series of consensus development meetings. We entered 42 outcomes, organized in 15 domains, into the Delphi survey. Two-hundred eighteen of 251 invitees (87%) provided responses (203 complete responses) for round 1 and 118 of 218 (42%) completed round2. Sixteen experts participated in the development meetings. The final outcome set includes 15 outcomes: 10 outcomes apply to all abortion trials (successful abortion, ongoing pregnancy, death, hemorrhage, uterine infection, hospitalization, surgical intervention, pain, gastrointestinal symptoms, and patients' experience of abortion); 2 outcomes apply to only surgical abortion trials (uterine perforation and cervical injury), one applies only to medical abortion trials (uterine rupture); and 2 apply to trials evaluating abortions with anesthesia (over-sedation/respiratory depression and local anesthetic systemic toxicity). Using robust consensus science methods we have developed a core outcome set for future abortion research. Standardized outcomes in abortion research could decrease heterogeneity among trials and improve the quality of systematic reviews and clinical guidelines. Researchers should select, collect, and report these core outcomes in future abortion trials. Journal editors should advocate for core outcome set reporting.

Identifiants

pubmed: 34273335
pii: S0010-7824(21)00224-9
doi: 10.1016/j.contraception.2021.07.004
pmc: PMC8609158
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-491

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Am J Obstet Gynecol. 2016 Apr;214(4):452-464
pubmed: 26778385
Womens Health Issues. 2014 Jan-Feb;24(1):e115-23
pubmed: 24439937
BMJ Sex Reprod Health. 2018 May 7;:
pubmed: 29972364
Pregnancy Hypertens. 2020 Jul;21:208-217
pubmed: 32674052
BJOG. 2020 Nov;127(12):1516-1526
pubmed: 32416644
Pregnancy Hypertens. 2016 Oct;6(4):274-278
pubmed: 27939467
BJOG. 2017 Nov;124(12):1829-1839
pubmed: 28432737
BJOG. 2019 Apr;126(5):637-646
pubmed: 30653799
Contraception. 2017 May;95(5):437-441
pubmed: 28065833
BJOG. 2017 Sep;124(10):1481-1489
pubmed: 28421657
BJOG. 2020 Jul;127(8):967-974
pubmed: 32227676
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
Fertil Steril. 2021 Jan;115(1):201-212
pubmed: 33272619
Am J Obstet Gynecol. 2019 Jan;220(1):71.e1-71.e4
pubmed: 30273584
Eur J Contracept Reprod Health Care. 2018 Dec;23(6):451-457
pubmed: 30600730
Contraception. 2017 Jul;96(1):1-13
pubmed: 28578150
Obstet Gynecol. 2016 Jan;127(1):49-58
pubmed: 26646133
Braz J Phys Ther. 2016 Jan 19;20(2):105-13
pubmed: 26786084
BJOG. 2017 Feb;124(3):366-369
pubmed: 28120536
Trials. 2016 May 04;17(1):230
pubmed: 27142835
Int J Gynaecol Obstet. 2017 Dec;139(3):262-267
pubmed: 28803445
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
Contraception. 2016 Aug;94(2):97-103
pubmed: 27129936
Patient Relat Outcome Meas. 2018 Nov 01;9:353-367
pubmed: 30464666
Hum Reprod. 2020 Dec 1;35(12):2725-2734
pubmed: 33252685
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161
pubmed: 32710833
Cochrane Database Syst Rev. 2012 Apr 13;(5):ED000041
pubmed: 22592744

Auteurs

Katherine C Whitehouse (KC)

The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland. Electronic address: kate.whitehouse@gmail.com.

Bianca M Stifani (BM)

Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, United States.

James M N Duffy (JMN)

Fetal Medicine Research Institute, London, UK.

Caron R Kim (CR)

The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Mitchell D Creinin (MD)

Department of Obstetrics and Gynecology, University of California, Davis, CA, United States.

Teresa DePiñeres (T)

Innovations in Reproductive Health, Miami, FL, United States.

Beverly Winikoff (B)

Gynuity Health Projects, New York, NY, United States.

Kristina Gemzell-Danielsson (K)

Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Jennifer Blum (J)

Gynuity Health Projects, New York, NY, United States.

Renee Bracey Sherman (RB)

We Testify, Washington, DC, United States.

Antonella F Lavelanet (AF)

The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Dalia Brahmi (D)

Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.

Daniel Grossman (D)

Advancing New Standards in Reproductive Health (ANSIRH), Department of Obstetrics, Gynecology and Reproductive Sciences, University of California - San Francisco, Oakland, CA, United States.

Anand Tamang (A)

Center for Research on Environment Health and Population Activities (CREHPA), Kathmandu, Nepal.

Hailemichael Gebreselassie (H)

Ipas, Chapel Hill, NC, United States.

Rodolfo Gomez Ponce de Leon (RG)

Latin American Center of Perinatology, Women and Reproductive Health (CLAP/WR), PAHO-WHO, Montevideo, Uruguay.

Bela Ganatra (B)

The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH